0001016353-15-000005.txt : 20150505 0001016353-15-000005.hdr.sgml : 20150505 20150505205405 ACCESSION NUMBER: 0001016353-15-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150501 FILED AS OF DATE: 20150505 DATE AS OF CHANGE: 20150505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACUCELA INC. CENTRAL INDEX KEY: 0001400482 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 020592619 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 SECOND AVE. STREET 2: SUITE 4200 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 206-805-8300 MAIL ADDRESS: STREET 1: 1301 SECOND AVE. STREET 2: SUITE 4200 CITY: SEATTLE STATE: WA ZIP: 98101 FORMER COMPANY: FORMER CONFORMED NAME: Acucela Inc DATE OF NAME CHANGE: 20070523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DANSE EDWARD H CENTRAL INDEX KEY: 0001016353 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55133 FILM NUMBER: 15834863 MAIL ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92715 4 1 wf-form4_143087363534656.xml FORM 4 X0306 4 2015-05-01 0 0001400482 ACUCELA INC. M?????? 0001016353 DANSE EDWARD H C/O ACUCELA INC. 1301 2ND AVE., SUITE 4200 SEATTLE WA 98101 0 1 0 0 Chief Business Officer Common Stock 2015-05-01 4 A 0 118369 0 A 118369 D The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192000). Mr. Danse was granted 118,369 shares of restricted stock which will be subject to repurchase by the issuer over a four (4) year period if the reporting person's employment is terminated, with 75% of the restricted stock subject to repurchase through 5/1/2016, and the remaining thereafter on a decreasing percentage on a monthly pro rata basis over the following three (3) years, terminating on 5/1/2019. /s/ John Gebhart as attorney-in-fact for Edward Danse 2015-05-05